Yissum Ltd. Introduces Novel Compound for the Treatment of Osteoporosis

JERUSALEM--(BUSINESS WIRE)--Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, introduced today a new compound for the treatment of osteoporosis. The new potential therapeutic will be presented by Professor Itai Bab from the Bone Laboratory, Institute of Dental Sciences at the Hebrew University of Jerusalem on Tuesday, June 16 at the Technology Transfer Session of the ILSI Biomed Israel 2009 conference, to be held at the David Intercontinental Hotel, Tel Aviv, Israel.